Диссертация (1174214), страница 51
Текст из файла (страница 51)
Vascular Calcification: In Vitro Evidence for the Role of InorganicPhosphate / C.M. Giachelli // J Am Soc Nephrol. – 2003. –Vol.14. –P. 300-304.295. Giannarelli, C. Effect of sulfaphenazole on tissue plasminogen activator release innormotensive subjects and hypertensive patients / C. Giannarelli, A. Virdis, F.
De Negriet al. //Circulation. – 2009. – Vol.119. – P. 1625-1633.296. Giles, R.E. Maternal inheritance of human mitochondrial DNA / R.E. Giles, H.Blanc, H.M. Cann et al. // Proc Natl Acad Sci USA. – 1980. – Vol.77. – P. 6715–9.297. Glaser, R. Stress-induced immune dysfunction: implications for health / R. Glaser,J.K. Kiecolt-Glaser // Nat Rev Immunol.
– 2005. – Vol.5. – P. 243 – 51.298. Glassock ,R. J. Ageing and the glomerular filtration rate: truths and consequences/ R. J. Glassock, C. Winearls // Trans. Amer. Clin. Climatol. Ass. –2009. – Vol.120. – P.419–428.299. Glassock, R.J. Is the Presence of Microalbuminuria a Relevant Marker of KidneyDisease ?/ R.J. Glassock // Curr Hypertens Rep.–2010. – Vol. 12(5). – P. 364–368.300. Go, A.S. Chronic kidney disease and the risks of death, cardiovascular events, andhospitalization / A.S. Go, G.M. Chertow, D. Fan et.
al. // N Engl J Med. – 2004. –Vol.351(13). – P. 1296–305.295301. Gonzalez-Suarez, E. Antagonistic effectsof telomerase on cancer and aging in K5mTert transgenic mice / E. Gonzalez-Suarez, C. Geserick, J.M. Flores et al. // Oncogene.– 2005. – Vol.24. – P. 2256–2270.302. Goode, G.K. Hyperlipidaemia, hypertension, and coronary heart disease / G.K.Goode, J.P. Miller, A.M. Heagerty // Lancet. – 1995. – Vol.354. – P.362–364.303.
Goon, P.K. Circulating endothelial cells: markers of vascular dysfunction / P.K.Goon, C.J. Boos, G.Y. Lip // Clin Lab. – 2005. – Vol.51. – P. 531-538.304. Gorenne, I. Vascular smooth muscle cell senescence in atherosclerosis / I. Gorenne,M. Kavurma, S. Scott et al. // Cardiovasc. Res. –2006. – Vol. – P. 9–17.305. Gotto, A.M. Relation between baseline and on-treatment lipid parameters and firstacute major coronary events in the Air force/Texas Coronary Atherosclerosis PreventionStudy (AFCAPS/TexCAPS) / A.M. Gotto, E. Whitney, E.A.
Stein et al. // Circulation. –2000. – Vol.101(5). – P.477–84.306. Gottsäter,M. Non-hemodynamicpredictors of arterialstiffnessafter17years of follow-up: the Malmö Diet and Cancer study / M. Gottsäter, G. Östling, M.Persson et al. // J Hypertens.– 2015. – Vol.33(5). – P. 957-65.307. Green, D.J. Flow-mediated dilation and cardiovascular event prediction: does nitricoxide matter? / D.J. Green, H. Jones, D. Thijssen et al.
// Hypertension. – 2011. – Vol.57(3). – P. 363–369.308. Grundy, S.M. Definition of Metabolic Syndrome:Report of the National Heart,Lung, and Blood Institute/American Heart Association Conference on Scientific IssuesRelated to Definition / S.M. Grundy, B.H. Brewer, J.I. Cleeman et al. // Circulation. –2004. – Vol.109. – P. 433–8.309. Grundy, S.M.
Implications of Recent Clinical Trials for the National CholesterolEducation Program Adult Treatment Panel III Guidelines/ S.M. Grundy, J.I. Cleeman,C.N. Merz et al. // Circulation. – 2004. – Vol.110. – P.227–39.310. Guerin, A.P. Arterial stiffening and vascular calcifications in end-stage renaldisease / A.P. Guerin, G.M. London, S.J.
Marchais et. al. // Nephrol Dial Transplant. –2000. – Vol.15. – P. 1014–1021.296311. Guevara-Aguirre, J. Growth hormone receptor defciency is associated with a majorreduction in pro-aging signaling, cancer, and diabetes in humans / J. Guevara-Aguirre, P.Balasubramanian, M. Guevara-Aguirre et al. //Sci Transl Med.
– 2011. – Vol.3. –P.70.312. Guzzardi, M.A. Rate of telomere shortening and metabolic and cardiovascular riskfactors: A longitudinal study in the 1934–44 Helsinki Birth Cohort Study / M.A.Guzzardi, P. Iozzo, M. Salonen et al. // Annals of medicine. – 2015. – Vol.47(6). – P.499–505.313. Gyllenborg, J. Cardiovascular risk factors in men: the role of gonadal steroids andsex hormone-binding globulin / J.
Gyllenborg, S.L. Rasmussen, K. Borch-Johnsen et al.//Metabolism. –2001. – Vol.50. – P. 882–888.314. Hackam, D. G. What level of plasma homocyst (e) ine should be treated? Effectsof vitamin therapy on progression of carotid atherosclerosis in patients with homocyst (e)ine levels above and below 14 micromol L / D. G. Hackam, J.C. Peterson, J.D. Spence //Amer.J. Hypertens. – 2000. – Vol.13. – P. 105–110.315. Haendeler, J. Mitochondrial telomerase reverse transcriptase binds to and protectsmitochondrial DNA and function from damage / J. Haendeler, S.
Dröse, N. Büchner etal. // Arterioscler Thromb Vasc Biol. – 2009. – Vol.29(6). – P. 929–935.316. Haendeler, J. Antioxidants inhibits nuclear export of telomerase reversetranscriptase and delay replicative senescence of endothelial cells / J.
Haendeler, J.Hoffmann, J.F. Diehl et al. // Circ Res. – 2004. – Vol.94. – P. 768–75.317. Haffner S.M. American Diabetes Association., Management of dyslipidaemia inadults with diabetes /S.M. Haffner // Diabetes Care. – 2003. – Vol.26. – P. 83–6.318.
Haffner, S.M. Mortality from coronary heart disease in subjects with type 2diabetes and in nondiabetic subjects with and without prior myocardial infarction / S.M.Haffner, S. Lehto, T. Ronnemaa et al. // N Engl J Med. –1998. – Vol.229. – P. 229– 234.319. Hajat, A. Examining the association between salivary cortisol levels andsubclinical measures of atherosclerosis: the Multi-Ethnic Study of Atherosclerosis / A.Hajat, A.V.
Diez-Roux, B.N. Sánchez et al. //Psychoneuroendocrinology. –2013. –Vol.38(7). – P. 1036-46.297320.Hamann, D. Faces and phases of human CD8 T-cell development / D. Hamann,M.T. Roos, R.A. van Lier // Immunol. Today. – 1999. – Vol.20(4). – P. 177–180.321. Hamel, E. Perivascular nerves and the regulation of cerebrovascular tone / E.Hamel // J Appl Physiol . – 2006. – Vol.100. – P. 1059-1064.322.
Hamer, M. Cortisol Responses to Mental Stress and the Progression of CoronaryArtery Calcification in Healthy Men and Women / M. Hamer, R. Endrighi, S.M. Venurajuet al. // PloS One. – 2012. – Vol.7. – 31356.323. Hanley, A.J. Homeostasis model assessment of insulin resistance in relation to theincidence of cardiovascular disease: the San Antonio Heart Study / A.J. Hanley, K.Williams, M.P. Stern et al. // Diabetes Care. – 2002. – Vol.25. – P.
1177– 1184.324. Hansen, M.E. Shorter telomere length in Europeans than in Africans due topolygenetic adaptation / M.E. Hansen, S.C. Hunt, R.C. Stone et al. // Hum. Mol. Genet.– 2016. – Vol.25. – P. 2324–2330.325. Hansson ,G.K. The immune response in atherosclerosis: a double-edged sword /G.K. Hansson, P. Libby // Nat Rev Immunol. – 2006. – Vol.6. – P. 508–19.326.
Harley, C.B. A natural product telomerase activator as part of a health maintenanceprogram / C.B. Harley, W. Liu, M. Blasco et al. // Rejuvenation Res. – 2011. – Vol.14(1).– P. 45–56327. Harman, D. Aging: a theory based on free radical and radiation chemistry / D.Harman //J Gerontol. – 1956. – Vol.11. – P. 298–300.328. Harrison, D. G. Inflammation, immunity, and hypertension / D. G. Harrison, T. J.Guzik, H. E. Lob et al. // Hypertension. – 2011. – Vol.57(2). – P. 132–140.329. Hatada, E.N. NF-kB and the innate immune response / E.N.
Hatada, D. Krappman,C. Scheidereit // Curr Opin Immunol. – 2000. – Vol.12. – P. 52–8.330. Hatada, T. Plasma concentrations and importance of High Mobility Group Boxprotein in the prognosis of organ failure in patients with disseminated intravascularcoagulation / T. Hatada, H. Wada, T. Nobori et al. //Thromb Haemost. – 2005. – Vol.94.– P. 975-979.331. Hatakeyama, H. Testosterone inhibits tumor necrosis factor-alpha-inducedvascular cell adhesion molecule-1 expression in human aortic endothelial cells / H.298Hatakeyama, M. Nishizawa, A.
Nakagawa et al. // FEBS Lett. – 2002. – Vol.530. – P.129–132.332. Haycock, P.C. Leucocyte telomere length and risk of cardiovascular disease:systematic review and meta-analysis / P.C. Haycock, E.E. Heydon, S. Kaptoge et al. //BMJ. – 2014. – Vol.8. – P. 349.333. Hayward, C.S. The roles of gender, the menopause and hormone replacement oncardiovascular function / C.S. Hayward, R.P. Kelly, P. Collins // Cardiovasc Res. – 2000.–Vol.46. – P.28–49.334. Heffetz, D. The insulinomimetic agents H2O2 and vanadate stimulate proteintyrosine phosphorylation in intact cells / D. Heffetz, I. Bushkin, R.
Dror et al. //J BiolChem. – 1990. – Vol.265. – P. 2896–2902.335. Heidinger, B.J. Telomere length in early life predicts lifespan / B.J. Heidinger, J.D.Blount, Boner et W. al. // Proc Natl Acad Sci U S A. – 2012. – Vol.109(5). – P. 1743–8.336. Heidt, T. Chronic variable stress activates hematopoietic stem cells / T. Heidt, H.B.Sager, G. Courties et al. // Nat. Med. – 2014. – Vol.20.
– P. 754–758.337. Heiss, G. Carotid atherosclerosis measured by B-mode ultrasound in population:associations with cardiovascular risk factors in the ARIC study / G. Heiss, A.R. Sharret,R. Barnes et al.// Am. J. Epidemiol. – 1991. – Vol.134. – P. 250-256.338. Helgadottir, A. Apolipoprotein(a) genetic sequence variants associated withsystemic atherosclerosis and coronary atherosclerotic burden but not with venousthromboembolism / A.
Helgadottir, S. Gretarsdottir, G. Thorleifsson et al. // J. Am. Coll.Cardiol. – 2012. – Vol.60. – P. 722–729.339. Hennekens, C.H. Lack of effect of long-term supplementation with beta caroteneon the incidence of malignant neoplasms and cardiovascular disease / C.H. Hennekens,J.E. Buring, J.E Manson. et al. // N Engl J Med. – 1996. – Vol.334. – P. 1145–9.340.
Herbert, K.E. Angiotensin II-mediated oxidative DNA damage accelerates cellularsenescence in cultured human vascular smooth muscle cells via telomere-dependent andindependent pathways / K.E. Herbert, Y. Mistry, R. Hastings et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
